BAYER 40 Pill - pink oval, 16mm
Generic Name: regorafenib
Pill with imprint BAYER 40 is Pink, Oval and has been identified as Stivarga 40 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc.
Stivarga is used in the treatment of Hepatocellular Carcinoma; Colorectal Cancer; Gastrointestinal Stromal Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Stivarga 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BAYER 40
Stivarga
- Generic Name
- regorafenib
- Imprint
- BAYER 40
- Strength
- 40 mg
- Color
- Pink
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC)
- 50419-0171
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
silicon dioxide,
ferric oxide red,
ferric oxide yellow,
soya lecithin,
polyethylene glycol 3350,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "BAYER 40"
More about Stivarga (regorafenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
